Genetic variations linked to weight loss, side effects from GLP-1 drugs (Reuters) - Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to genetic variants, according to a study conducted by DNA-testing service 23AndMe
Secondary Carnitine Deficiency: Treatment of deficiency associated with inborn errors of metabolism (e.g., organic acidurias)
doi:10.1242/jeb.00861
Slow injection: Push the plunger slowly and pause a few seconds before withdrawing the needle to prevent backflow
They should not be used in patients with: Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Pancreatitis: Inflammation of the pancreas (0.1-0.5% of patients) Symptoms: Severe abdominal pain that doesnt go away, with or without vomiting Action: Stop medication immediately and contact your healthcare provider Gallbladder Problems: Including gallstones (1-2% requiring surgery) Symptoms: Upper abdominal pain, fever, yellowing of skin or eyes Action: Seek immediate medical attention Kidney Problems: Particularly with severe dehydration from vomiting or diarrhea Prevention: Maintain adequate hydration throughout treatment Hypoglycemia: Low blood sugar, particularly in patients taking other diabetes medications Monitoring: Regular blood sugar checks if you have diabetes Safety Profile Comparison: SURMOUNT-5 Results In the head-to-head SURMOUNT-5 trial: Overall safety profiles were similar between Zepbound and Wegovy Most adverse events were gastrointestinal and mild to moderate Serious adverse events: 4.8% with Zepbound vs
While research backs the above weight loss tips, diet and exercise alone may not be enough for everyone
)
